Business Context and Reporting Period
Company: AMN Healthcare Services, Inc.
Filing Type: Form 10-Q (Quarterly Report)
Period Ended: September 30, 2009
Business Overview: The Company is a leading provider of healthcare staffing and management services, operating through three segments: Nurse and Allied Healthcare Staffing, Locum Tenens Staffing, and Physician Permanent Placement Services. The reporting period reflects significant impacts from the economic downturn, resulting in reduced demand for temporary staffing and substantial asset impairments.
Key Financial Metrics
| Metric (in thousands) | Three Months Ended Sep 30, 2009 |
Nine Months Ended Sep 30, 2009 |
Nine Months Ended Sep 30, 2008 |
|---|---|---|---|
| Revenue | $166,357 | $615,092 | $921,298 |
| Gross Profit | $45,608 | $163,268 | $241,053 |
| Gross Margin | 27.4% | 26.5% | 26.2% |
| Net Income (Loss) | $(1,995) | $(119,455) | $26,733 |
| Diluted EPS | $(0.06) | $(3.66) | $0.78 |
| Operating Cash Flow (9mo) | $93,150 | ||
| Cash and Equivalents | $22,621 (as of Sep 30, 2009) | ||
| Total Debt (Notes Payable) | $77,270 (Current + Long-term) |
Note: The Nine Month 2009 Net Loss includes $175.7 million in impairment charges and $11.3 million in restructuring charges.
Material Changes vs. Prior Period
- Revenue Decline: Revenue decreased 47% in the quarter and 33% for the nine months compared to 2008. The Nurse and Allied Healthcare segment saw a 62% quarterly drop, driven by a significant reduction in the average number of temporary professionals on assignment due to the economic downturn.
- Asset Impairments: The Company recorded a pre-tax goodwill impairment charge of $173.0 million and an indefinite-lived intangible asset impairment of $2.7 million in the first quarter of 2009. This was triggered by a decline in market capitalization and lower projected growth rates.
- Restructuring: Restructuring charges of $11.3 million were recorded for the nine months ended September 30, 2009, related to office consolidations, branding strategy adjustments, and headcount reductions.
- Debt Reduction: The Company aggressively reduced debt, paying down $69.0 million in revolving credit and notes payable since December 31, 2008. The revolving credit facility balance dropped from $31.5 million to zero.
- Working Capital: Days Sales Outstanding (DSO) improved from 57 days (Dec 31, 2008) to 53 days (Sep 30, 2009), contributing to strong operating cash flow despite lower revenues.
Outlook, Risks, and Management Commentary
- Market Conditions: Demand for travel nursing has stabilized in the latter part of Q3 but remains below historical levels. Hospitals are relying more on permanent staff due to budget constraints. Locum tenens demand is impacted by lower elective surgeries and reimbursement changes, though dentistry shows growth.
- Cost Management: Management has centralized back-office functions and consolidated offices to reduce the cost structure. They expect to utilize restructuring accruals by 2011.
- Liquidity: The Company believes cash from operations and available credit ($54.2 million remaining on the revolver) are sufficient for the next 12 months. A credit agreement amendment in May 2009 extended the revolver maturity to November 2011 and adjusted leverage covenants.
- Subsequent Event: On October 15, 2009, the Board approved an equity exchange program (subject to shareholder vote) allowing employees to exchange stock options/SARs for restricted stock units (RSUs).
- Risks: Key risks include the ability to sustain business in an economic downturn, healthcare reform legislation, changes in Medicare reimbursement rates, and the classification of healthcare professionals as independent contractors.
Investor Verification Checklist
- Impairment Finalization: Verify that the $175.7 million goodwill impairment charge is fully recognized and no further charges are anticipated in the near term.
- Revenue Stabilization: Monitor subsequent quarters to confirm if the "stabilization" in travel nursing demand mentioned in Q3 persists or if volumes continue to contract.
- Debt Covenants: Review the amended credit agreement terms, specifically the Adjusted EBITDA floor of $45.0 million and leverage ratios, to ensure ongoing compliance.
- Equity Exchange Impact: Assess the potential incremental compensation expense resulting from the proposed equity exchange program if approved by shareholders.
- Accounts Receivable Quality: Given the economic environment, verify the adequacy of the allowance for doubtful accounts ($5.6 million as of Sep 30, 2009) against client collectability risks.